Product Information
CHARLOTTE 24 FE CHEWABLE TAB is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.3041 per EA under NDC 68462085229. Its NADAC has been published 323 times since Jul 29, 2020.
FDA first approved this application on Dec 26, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
CHARLOTTE 24 FE CHEWABLE TAB
norethindrone acetate and ethinyl estradiol and ferrous fumarateManufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462085229
Classification
Generic
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA210369FDA Approved
12/26/2017
TE Code
AB
On Market Since
2/20/2020
Price Statistics
The NADAC for CHARLOTTE 24 FE CHEWABLE TAB has been published 323 times since Jul 29, 2020, and over the history we have for it it has declined 83.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3041 per EA |
|---|---|
| All-time high | $2.4231 (Sep 16, 2020) |
| All-time low | $0.1310 (Oct 18, 2023) |
| 52-week high | $0.4407 |
| 52-week low | $0.2203 |
| Median price | $0.3340 |
| Average price | $0.5128 |
| Largest weekly change | +89.1% (Nov 22, 2023) |
| Weeks tracked | 323 |
| Tracking since | Jul 29, 2020 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 58% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Glenmark Pharmaceuticals Inc., USA manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
norethindrone acetate and ethinyl estradiol and ferrous fumarate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CHARLOTTE 24 FE CHEWABLE TAB?
The current National Average Drug Acquisition Cost (NADAC) for CHARLOTTE 24 FE CHEWABLE TAB, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.3041 per EA (NDC 68462085229), effective Sep 30, 2026.
How has the price of CHARLOTTE 24 FE CHEWABLE TAB changed over time?
Over the history we have for it, the NADAC for CHARLOTTE 24 FE CHEWABLE TAB has declined 83.3%. It has been tracked across 323 weekly CMS publications since Jul 29, 2020.
What are the highest and lowest recorded NADAC prices for CHARLOTTE 24 FE CHEWABLE TAB?
Since Jul 29, 2020, the NADAC for CHARLOTTE 24 FE CHEWABLE TAB has ranged from a low of $0.1310 (Oct 18, 2023) to a high of $2.4231 (Sep 16, 2020), with a median of $0.3340 per EA.
Are there cheaper alternatives to CHARLOTTE 24 FE CHEWABLE TAB?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HAILEY FE 1-20 TABLET, is $0.1287 per EA — about 58% below CHARLOTTE 24 FE CHEWABLE TAB.
Who manufactures CHARLOTTE 24 FE CHEWABLE TAB?
CHARLOTTE 24 FE CHEWABLE TAB (NDC 68462085229) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.